CTLA4 and malignant colon neoplasm: As a crucial immune checkpoint, the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blockade Ab has demonstrated encouraging anti-tumor effects in various cancers, including lung cancer, melanoma, and colon cancer [7,8,9].